IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Polaris Venture Management Co. V, L.L.C.

Q1 2015 Holdings

Filed 2015-05-14 | 7 holdings | $223.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ocular Therapeutix, Inc.(OCUL)Common Stock67576A100$85.2K2,030,00938.1%
T2 Biosystems, Inc.Common Stock89853L104$36.9K2,374,57116.5%
Cerulean Pharma IncCommon Stock15708Q105$29.6K3,287,52913.2%
Trevena, Inc.Common Stock89532E109$24.6K3,769,28011.0%
Genocea Biosciences, Inc.Common Stock372427104$24.4K2,055,23010.9%
Fate Therapeutics, Inc.(FATE)Common Stock31189P102$12.1K2,473,1865.4%
Bind Therapeutics, Inc.Common Stock05548N107$11.1K2,018,2535.0%